| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | EVP, Commercial Operations | EVP, Chief Commercial Officer +2 more
1 company
Stewart Jeffrey Ryan is an EVP, Chief Commercial Officer at AbbVie Inc.. Recent SEC Form 4 filings include 1 buy and 15 sells.
Estimated insider holdings value: $24.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | ABBV Abbvie Inc. | EVP, Chief Commercial Officer | Sale+OE | 58,832 | $210.08 | $12,359,504.28 | -29.6% | -11.4% | +3.8% | |
| Mar 18, 2024 | ABBV Abbvie Inc. | EVP, Chief Commercial Officer | Sale+OE | 58,949 | $178.79 | $10,539,508.07 | -19.5% | -4.9% | +19.8% | |
| Mar 13, 2023 | ABBV Abbvie Inc. | EVP, Chief Commercial Officer | Sale+OE | 53,125 | $152.28 | $8,089,998.05 | -25.7% | -9.4% | +19.1% | |
| Mar 24, 2022 | ABBV Abbvie Inc. | EVP, Chief Commercial Officer | Sale+OE | 27,690 | $159.20 | $4,408,375.37 | -31.2% | -7.2% | +1.4% | |
| Mar 1, 2022 | ABBV Abbvie Inc. | EVP, Chief Commercial Officer | Sell | 21,488 | $148.25 | $3,185,598.56 | -9.7% | +0.6% | +8.1% | |
| Dec 15, 2021 | ABBV Abbvie Inc. | EVP, Chief Commercial Officer | Sell | 2,152 | $128.00 | $275,456.00 | -4.4% | +20.9% | +30.1% | |
| Mar 1, 2021 | ABBV Abbvie Inc. | SVP, Us Commercial Operations | Sell | 13,773 | $108.59 | $1,495,575.64 | -21.3% | +4.8% | +42.6% | |
| Dec 29, 2020 | ABBV Abbvie Inc. | EVP, Commercial Operations | Sale+OE | 25,290 | $105.00 | $2,655,450.00 | -33.2% | - | - | |
| May 12, 2020 | ABBV Abbvie Inc. | SVP, Us Commercial Operations | Sell | 23,024 | $90.00 | $2,072,210.65 | -30.4% | - | - | |
| Aug 16, 2019 | ABBV Abbvie Inc. | SVP, Us Commercial Operations | Buy | 15,552 | $64.44 | $1,002,169.32 | +31.3% | - | - |